IP Library Granted Patent US 7,067,139
Granted Patent B2
US 7,067,139 · App. 09/316,624 · Granted Jun 27, 2006

Method for treating autoimmune diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,139
App. No.
09/316,624
Granted
Jun 27, 2006
Kind
B2
Abstract

A method of treating patients having rheumatoid arthritis by administering Product R, a peptide-nucleic acid preparation, is disclosed.

Claims (6)

1. A method of ameliorating a symptom of rheumatoid arthritis in a patient suffering from rheumatoid arthritis, comprising parenterally administering to said patient an effective symptom ameliorating amount of Product R in a range from about 2.5 microliters to about 40 microliters per kilogram of body weight per day in a pharmaceutically acceptable formulation.

2. The method of claim 1 wherein said Product R is administered in a range from about 5 microliters to about 25 microliters per kilogram of body weight per day.

3. The method of claim 1 wherein said Product R is administered in amout of about 7.5 microliters per kilogram of body weight per day.

4. A method of ameliorating a symptom of rheumatoid arthritis in a patient suffering from rheumatoid arthritis, comprising the steps of:

a. parenterally administering Product R to said patient an elective symptom ameliorating amount of about 1 ml twice per day in a pharmaceutically acceptable formulation for about 15 days; and

b. parenteraly administering Product R to said patient an effective symptom ameliorating amount of about 1 ml once per day in a pharmaceutically acceptable formulation for about 75 days after step a.

Assignments (5)
MERGER Recorded Dec 30, 2013
From: BBM HOLDINGS, INC.
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 031859/0049 →
SECURITY AGREEMENT Recorded May 20, 2009
From: BBM HOLDINGS, INC.
To: YA GLOBAL INVESTMENTS, L.P.
Reel/Frame 022708/0679 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY PREVIOUSLY RECORDED ON REEL 022542 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE OWNERSHIP TRANSFERED FROM ADVANCED VIRAL RESEARCH CORP. AND TRIAD BIOTHERAPEUTICS, INC. TO BBM HOLDINGS, INC. Recorded Apr 30, 2009
From: ADVANCED VIRAL RESEARCH CORP.; TRIAD BIOTHERAPEUTICS, INC.
To: BBM HOLDINGS, INC.
Reel/Frame 022629/0569 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR/ASSIGNEE NAMES PREVIOUSLY RECORDED ON REEL 022510 FRAME 0187. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNORS ARE ADVANCED VIRAL RESEARCH CORP. AND TRIAD BIOTHERAPEUTICS, INC., AND THE ASSIGNEE IS YA GLOBAL INVESTMENTS, L.P. Recorded Apr 14, 2009
From: ADVANCED VIRAL RESEARCH CORP.; TRIAD BIOTHERAPEUTICS, INC.
To: YA GLOBAL INVESTMENTS, L.P. (F/K/A CORNELL CAPITAL PARTNERS, L.P.)
Reel/Frame 022542/0001 →
FORECLOSURE BY THIRD PARTY Recorded Apr 6, 2009
From: YA GLOBAL INVESTMENTS, L.P. (F/K/A CORNELL CAPITAL PARTNERS, L.P.)
To: ADVANCED VIRAL RESEARCH CORP.; TRIAD BIOTHERAPEUTICS, INC.
Reel/Frame 022510/0187 →